Cekic, Caglar
Linden, Joel
Article History
First Online: 29 February 2016
Competing interests
: J.L. owns equity in Adenosine Therapeutics, LLC and Lewis and Clark Pharmaceuticals. These companies are developing drugs that target adenosine receptors.